Pfizer Amgen: That Pfizer’s Seagen Bet Could Lead
Pfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
Why Avoid Individual Stocks highlights the risks of single-stock bets and why broad index funds offer steadier long-term growth for most investors.
21,808 articlesPfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
Investors are buzzing about what happening with quantumscape. This article breaks down the core catalysts, risks, and...
A high-stakes pivot: the team behind ethereum's institutional privacy push launches EthSystems, a for-profit venture ...
Mortgage rates sit above 6.6%, yet early 2026 data suggest the housing market still grow. This report breaks down wha...
ExxonMobil is not just drilling and refining anymore. This article explores how the company might evolve toward a bro...
SpaceX is pursuing orbital data centers to move AI workloads closer to data sources. If the program scales, NVIDIA co...
Argentina unveils an investment citizenship program aimed at foreign investors, signaling a bid to become a migration...
Apollo-owned Michaels is reshaping its business by absorbing assets from rival bankruptcies, expanding party and fabr...
A closer look at Janus Henderson's CLO ETFs shows a safety-first anchor in JAAA and a bolder, higher-yield challenger...
Global container rates surge again amid geopolitical tension and tariff uncertainty, reviving concerns about another ...
Consensys says a third-party contractor linked to North Korea accessed MetaMask code for roughly a month before acces...
New surveys reveal a sharp contrast: americans trust financial advice from employers, yet a growing share doubt they’...